Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 57

1.

American Head and Neck Society Endocrine Section clinical consensus statement: North American quality statements and evidence-based multidisciplinary workflow algorithms for the evaluation and management of thyroid nodules.

Meltzer CJ, Irish J, Angelos P, Busaidy NL, Davies L, Dwojak S, Ferris RL, Haugen BR, Harrell RM, Haymart MR, McIver B, Mechanick JI, Monteiro E, Morris JC 3rd, Morris LGT, Odell M, Scharpf J, Shaha A, Shin JJ, Shonka DC Jr, Thompson GB, Tuttle RM, Urken ML, Wiseman SM, Wong RJ, Randolph G.

Head Neck. 2019 Apr;41(4):843-856. doi: 10.1002/hed.25526. Epub 2018 Dec 18.

PMID:
30561068
2.

NCCN Guidelines Insights: Thyroid Carcinoma, Version 2.2018.

Haddad RI, Nasr C, Bischoff L, Busaidy NL, Byrd D, Callender G, Dickson P, Duh QY, Ehya H, Goldner W, Haymart M, Hoh C, Hunt JP, Iagaru A, Kandeel F, Kopp P, Lamonica DM, McIver B, Raeburn CD, Ridge JA, Ringel MD, Scheri RP, Shah JP, Sippel R, Smallridge RC, Sturgeon C, Wang TN, Wirth LJ, Wong RJ, Johnson-Chilla A, Hoffmann KG, Gurski LA.

J Natl Compr Canc Netw. 2018 Dec;16(12):1429-1440. doi: 10.6004/jnccn.2018.0089.

PMID:
30545990
3.

Thyroid Ultrasound and the Increase in Diagnosis of Low-Risk Thyroid Cancer.

Haymart MR, Banerjee M, Reyes-Gastelum D, Caoili E, Norton EC.

J Clin Endocrinol Metab. 2019 Mar 1;104(3):785-792. doi: 10.1210/jc.2018-01933.

PMID:
30329071
4.

Association of the Word Cancer With Thyroid Cancer Treatment Decisions-A Rose by Any Other Name.

Haymart MR.

JAMA Otolaryngol Head Neck Surg. 2018 Oct 1;144(10):896. doi: 10.1001/jamaoto.2018.1813. No abstract available.

PMID:
30140895
5.

South Korean Thyroid Cancer Trends: Good News and Bad.

Haymart MR, Davies L.

Thyroid. 2018 Sep;28(9):1081-1082. doi: 10.1089/thy.2018.0508. No abstract available.

PMID:
30113268
6.

Limitations of the 2015 ATA Guidelines for Prediction of Thyroid Cancer: A Review of 1947 Consecutive Aspirations.

Pandya A, Caoili EM, Jawad-Makki F, Wasnik AP, Shankar PR, Bude R, Haymart MR, Davenport MS.

J Clin Endocrinol Metab. 2018 Sep 1;103(9):3496-3502. doi: 10.1210/jc.2018-00792.

PMID:
29982716
7.

Treatment-Free Survival in Patients With Differentiated Thyroid Cancer.

Banerjee M, Reyes-Gastelum D, Haymart MR.

J Clin Endocrinol Metab. 2018 Jul 1;103(7):2720-2727. doi: 10.1210/jc.2018-00511.

PMID:
29788217
8.

Is BRAF V600E Mutation the Explanation for Age-Associated Mortality Risk in Patients With Papillary Thyroid Cancer?

Haymart MR.

J Clin Oncol. 2018 Feb 10;36(5):433-434. doi: 10.1200/JCO.2017.76.2583. Epub 2017 Dec 14. No abstract available.

PMID:
29240539
9.

Active Surveillance for Low-Risk Cancers - A Viable Solution to Overtreatment?

Haymart MR, Miller DC, Hawley ST.

N Engl J Med. 2017 Jul 20;377(3):203-206. doi: 10.1056/NEJMp1703787. No abstract available.

10.

Controversies in the Management of Low-Risk Differentiated Thyroid Cancer.

Haymart MR, Esfandiari NH, Stang MT, Sosa JA.

Endocr Rev. 2017 Aug 1;38(4):351-378. doi: 10.1210/er.2017-00067. Review.

11.

REFERRAL OF OLDER THYROID CANCER PATIENTS TO A HIGH-VOLUME SURGEON: RESULTS OF A MULTIDISCIPLINARY PHYSICIAN SURVEY.

Papaleontiou M, Gauger PG, Haymart MR.

Endocr Pract. 2017 Jul;23(7):808-815. doi: 10.4158/EP171788.OR. Epub 2017 May 23.

12.

Population-Based Assessment of Complications Following Surgery for Thyroid Cancer.

Papaleontiou M, Hughes DT, Guo C, Banerjee M, Haymart MR.

J Clin Endocrinol Metab. 2017 Jul 1;102(7):2543-2551. doi: 10.1210/jc.2017-00255.

13.

Skeletal Complications and Mortality in Thyroid Cancer: A Population-Based Study.

Choksi P, Papaleontiou M, Guo C, Worden F, Banerjee M, Haymart M.

J Clin Endocrinol Metab. 2017 Apr 1;102(4):1254-1260. doi: 10.1210/jc.2016-3906.

14.

How Much Should Thyroid Cancer Impact Plans for Pregnancy?

Haymart MR, Pearce EN.

Thyroid. 2017 Mar;27(3):312-314. doi: 10.1089/thy.2016.0637. Epub 2017 Jan 12. No abstract available.

PMID:
27960612
15.

INAPPROPRIATE USE OF SUPPRESSIVE DOSES OF THYROID HORMONE IN THYROID NODULE MANAGEMENT: RESULTS FROM A NATIONWIDE SURVEY.

Papaleontiou M, Haymart MR.

Endocr Pract. 2016 Nov;22(11):1358-1360. No abstract available.

16.
17.

Retrospective Study of Sirolimus and Cyclophosphamide in Patients with Advanced Differentiated Thyroid Cancers.

Manohar PM, Beesley LJ, Taylor JM, Hesseltine E, Haymart MR, Esfandiari NH, Hanauer DA, Worden FP.

J Thyroid Disord Ther. 2015 Aug;4(3). pii: 188. Epub 2015 Jul 17.

18.

THE IMPACT OF AGE IN THE MANAGEMENT OF HYPOTHYROIDISM: RESULTS OF A NATIONWIDE SURVEY.

Papaleontiou M, Gay BL, Esfandiari NH, Hawley ST, Haymart MR.

Endocr Pract. 2016 Jun;22(6):708-15. doi: 10.4158/EP151021.OR. Epub 2016 Feb 1.

19.

Conditional survival in advanced colorectal cancer and surgery.

Wancata LM, Banerjee M, Muenz DG, Haymart MR, Wong SL.

J Surg Res. 2016 Mar;201(1):196-201. doi: 10.1016/j.jss.2015.10.021. Epub 2015 Oct 23.

20.

Effect of Thyrotropin Suppression Therapy on Bone in Thyroid Cancer Patients.

Papaleontiou M, Hawley ST, Haymart MR.

Oncologist. 2016 Feb;21(2):165-71. doi: 10.1634/theoncologist.2015-0179. Epub 2015 Dec 9. Review.

21.

Implications of age and conditional survival estimates for patients with melanoma.

Banerjee M, Lao CD, Wancata LM, Muenz DG, Haymart MR, Wong SL.

Melanoma Res. 2016 Feb;26(1):77-82. doi: 10.1097/CMR.0000000000000213.

22.

Anaplastic Thyroid Carcinoma, Version 2.2015.

Haddad RI, Lydiatt WM, Ball DW, Busaidy NL, Byrd D, Callender G, Dickson P, Duh QY, Ehya H, Haymart M, Hoh C, Hunt JP, Iagaru A, Kandeel F, Kopp P, Lamonica DM, McCaffrey JC, Moley JF, Parks L, Raeburn CD, Ridge JA, Ringel MD, Scheri RP, Shah JP, Smallridge RC, Sturgeon C, Wang TN, Wirth LJ, Hoffmann KG, Hughes M.

J Natl Compr Canc Netw. 2015 Sep;13(9):1140-50.

23.

AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY DISEASE STATE CLINICAL REVIEW: THE INCREASING INCIDENCE OF THYROID CANCER.

Davies L, Morris LG, Haymart M, Chen AY, Goldenberg D, Morris J, Ogilvie JB, Terris DJ, Netterville J, Wong RJ, Randolph G; AACE Endocrine Surgery Scientific Committee.

Endocr Pract. 2015 Jun;21(6):686-96. doi: 10.4158/EP14466.DSCR. Review.

24.

Evaluating Positron Emission Tomography Use in Differentiated Thyroid Cancer.

Wiebel JL, Esfandiari NH, Papaleontiou M, Worden FP, Haymart MR.

Thyroid. 2015 Sep;25(9):1026-32. doi: 10.1089/thy.2015.0062. Epub 2015 Aug 3.

25.

Inappropriate Use of Radioactive Iodine for Low-Risk Papillary Thyroid Cancer Is Most Common in Regions with Poor Access to Healthcare.

Marti JL, Davies L, Haymart MR, Roman BR, Tuttle RM, Morris LG.

Thyroid. 2015 Jul;25(7):865-6. doi: 10.1089/thy.2015.0112. Epub 2015 May 28. No abstract available.

26.

Trends in imaging after diagnosis of thyroid cancer.

Wiebel JL, Banerjee M, Muenz DG, Worden FP, Haymart MR.

Cancer. 2015 May 1;121(9):1387-94. doi: 10.1002/cncr.29210. Epub 2015 Jan 6.

27.

Thyroid carcinoma, version 2.2014.

Tuttle RM, Haddad RI, Ball DW, Byrd D, Dickson P, Duh QY, Ehya H, Haymart M, Hoh C, Hunt JP, Iagaru A, Kandeel F, Kopp P, Lamonica DM, Lydiatt WM, McCaffrey J, Moley JF, Parks L, Raeburn CD, Ridge JA, Ringel MD, Scheri RP, Shah JP, Sherman SI, Sturgeon C, Waguespack SG, Wang TN, Wirth LJ, Hoffmann KG, Hughes M.

J Natl Compr Canc Netw. 2014 Dec;12(12):1671-80; quiz 1680.

PMID:
25505208
28.

Conditional survival in patients with thyroid cancer.

Banerjee M, Muenz DG, Worden FP, Wong SL, Haymart MR.

Thyroid. 2014 Dec;24(12):1784-9. doi: 10.1089/thy.2014.0264.

29.

Tree-based model for thyroid cancer prognostication.

Banerjee M, Muenz DG, Chang JT, Papaleontiou M, Haymart MR.

J Clin Endocrinol Metab. 2014 Oct;99(10):3737-45. doi: 10.1210/jc.2014-2197. Epub 2014 Jul 17.

30.

New insights in risk stratification of differentiated thyroid cancer.

Papaleontiou M, Haymart MR.

Curr Opin Oncol. 2014 Jan;26(1):1-7. doi: 10.1097/CCO.0000000000000022. Review.

31.

The effect of extent of surgery and number of lymph node metastases on overall survival in patients with medullary thyroid cancer.

Esfandiari NH, Hughes DT, Yin H, Banerjee M, Haymart MR.

J Clin Endocrinol Metab. 2014 Feb;99(2):448-54. doi: 10.1210/jc.2013-2942. Epub 2013 Nov 25.

32.

Marginal treatment benefit in anaplastic thyroid cancer.

Haymart MR, Banerjee M, Yin H, Worden F, Griggs JJ.

Cancer. 2013 Sep 1;119(17):3133-9. doi: 10.1002/cncr.28187. Epub 2013 Jul 9.

33.

Clinical practice guideline: improving voice outcomes after thyroid surgery.

Chandrasekhar SS, Randolph GW, Seidman MD, Rosenfeld RM, Angelos P, Barkmeier-Kraemer J, Benninger MS, Blumin JH, Dennis G, Hanks J, Haymart MR, Kloos RT, Seals B, Schreibstein JM, Thomas MA, Waddington C, Warren B, Robertson PJ; American Academy of Otolaryngology-Head and Neck Surgery.

Otolaryngol Head Neck Surg. 2013 Jun;148(6 Suppl):S1-37. doi: 10.1177/0194599813487301.

PMID:
23733893
34.

The relationship between extent of thyroid cancer surgery and use of radioactive iodine.

Haymart MR, Banerjee M, Yang D, Stewart AK, Doherty GM, Koenig RJ, Griggs JJ.

Ann Surg. 2013 Aug;258(2):354-8. doi: 10.1097/SLA.0b013e31826c8915.

35.

Variation in the management of thyroid cancer.

Haymart MR, Banerjee M, Yang D, Stewart AK, Sisson JC, Koenig RJ, Doherty GM, Griggs JJ.

J Clin Endocrinol Metab. 2013 May;98(5):2001-8. doi: 10.1210/jc.2012-3355. Epub 2013 Mar 28.

36.

Referral patterns for patients with high-risk thyroid cancer.

Haymart MR, Banerjee M, Yang D, Stewart AK, Griggs JJ, Sisson JC, Koenig RJ.

Endocr Pract. 2013 Jul-Aug;19(4):638-43. doi: 10.4158/EP12288.OR.

37.

Surgeon training and use of radioactive iodine in stage I thyroid cancer patients.

Schuessler KM, Banerjee M, Yang D, Stewart AK, Doherty GM, Haymart MR.

Ann Surg Oncol. 2013 Mar;20(3):733-8. doi: 10.1245/s10434-012-2745-0. Epub 2012 Dec 6.

38.

Factors that influence radioactive iodine use for thyroid cancer.

Papaleontiou M, Banerjee M, Yang D, Sisson JC, Koenig RJ, Haymart MR.

Thyroid. 2013 Feb;23(2):219-24. doi: 10.1089/thy.2012.0380.

39.

The role of clinicians in determining radioactive iodine use for low-risk thyroid cancer.

Haymart MR, Banerjee M, Yang D, Stewart AK, Koenig RJ, Griggs JJ.

Cancer. 2013 Jan 15;119(2):259-65. doi: 10.1002/cncr.27721. Epub 2012 Jun 28.

40.

Approach to and treatment of thyroid disorders in the elderly.

Papaleontiou M, Haymart MR.

Med Clin North Am. 2012 Mar;96(2):297-310. doi: 10.1016/j.mcna.2012.01.013. Epub 2012 Feb 14. Review.

41.

American Thyroid Association consensus review and statement regarding the anatomy, terminology, and rationale for lateral neck dissection in differentiated thyroid cancer.

Stack BC Jr, Ferris RL, Goldenberg D, Haymart M, Shaha A, Sheth S, Sosa JA, Tufano RP; American Thyroid Association Surgical Affairs Committee.

Thyroid. 2012 May;22(5):501-8. doi: 10.1089/thy.2011.0312. Epub 2012 Mar 21. Review.

42.

Use of radioactive iodine for thyroid cancer.

Haymart MR, Banerjee M, Stewart AK, Koenig RJ, Birkmeyer JD, Griggs JJ.

JAMA. 2011 Aug 17;306(7):721-8. doi: 10.1001/jama.2011.1139.

43.

The most commonly occurring papillary thyroid cancer in the United States is now a microcarcinoma in a patient older than 45 years.

Hughes DT, Haymart MR, Miller BS, Gauger PG, Doherty GM.

Thyroid. 2011 Mar;21(3):231-6. doi: 10.1089/thy.2010.0137. Epub 2011 Jan 26.

44.

Thyroid hormone replacement in women of reproductive age: is surgeon knowledge related to operative volume?

Haymart MR, Cayo MA, Chen H.

Thyroid. 2010 Jun;20(6):627-31. doi: 10.1089/thy.2009.0320.

45.
46.

Papillary thyroid microcarcinomas: big decisions for a small tumor.

Haymart MR, Cayo M, Chen H.

Ann Surg Oncol. 2009 Nov;16(11):3132-9. doi: 10.1245/s10434-009-0647-6. Epub 2009 Aug 4.

47.

Understanding the relationship between age and thyroid cancer.

Haymart MR.

Oncologist. 2009 Mar;14(3):216-21. doi: 10.1634/theoncologist.2008-0194. Epub 2009 Mar 6. Review.

48.

Higher serum TSH in thyroid cancer patients occurs independent of age and correlates with extrathyroidal extension.

Haymart MR, Glinberg SL, Liu J, Sippel RS, Jaume JC, Chen H.

Clin Endocrinol (Oxf). 2009 Sep;71(3):434-9. doi: 10.1111/j.1365-2265.2008.03489.x. Epub 2008 Dec 3.

49.

Valproic acid activates Notch1 signaling and induces apoptosis in medullary thyroid cancer cells.

Greenblatt DY, Cayo MA, Adler JT, Ning L, Haymart MR, Kunnimalaiyaan M, Chen H.

Ann Surg. 2008 Jun;247(6):1036-40. doi: 10.1097/SLA.0b013e3181758d0e.

50.

The role of intraoperative frozen section if suspicious for papillary thyroid cancer.

Haymart MR, Greenblatt DY, Elson DF, Chen H.

Thyroid. 2008 Apr;18(4):419-23. doi: 10.1089/thy.2007.0272.

PMID:
18352821

Supplemental Content

Loading ...
Support Center